These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 34928552)
1. Corneal Perforation in Patients Under Treatment With Dupilumab for Atopic Dermatitis. Phylactou M; Jabbour S; Ahmad S; Vasquez-Perez A Cornea; 2022 Aug; 41(8):981-985. PubMed ID: 34928552 [TBL] [Abstract][Full Text] [Related]
2. Corneal Complications Related to Dupilumab Use. Tauber J; Ritterband DC; Kang JJ Eye Contact Lens; 2024 Jun; 50(6):270-273. PubMed ID: 38661491 [TBL] [Abstract][Full Text] [Related]
3. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis. Liberman P; Shifera AS; Berkenstock M Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517 [TBL] [Abstract][Full Text] [Related]
4. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients. Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603 [TBL] [Abstract][Full Text] [Related]
5. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma. Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203 [TBL] [Abstract][Full Text] [Related]
6. Tectonic keratoplasty for peripheral ulcerative keratitis. Raizman MB; Sainz de la Maza M; Foster CS Cornea; 1991 Jul; 10(4):312-6. PubMed ID: 1889217 [TBL] [Abstract][Full Text] [Related]
7. Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis. Li G; Berkenstock M; Soiberman U Am J Ophthalmol Case Rep; 2020 Sep; 19():100848. PubMed ID: 32793843 [TBL] [Abstract][Full Text] [Related]
8. [Ocular symptoms associated with dupilumab in atopic dermatitis]. Voorberg AN; Oosterhaven JAF; Wijdh RHJ; de Bruin-Weller MS; Schuttelaar MLA Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945835 [TBL] [Abstract][Full Text] [Related]
9. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records. Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499 [TBL] [Abstract][Full Text] [Related]
11. Case Report: Use of Amniotic Membrane for Tectonic Repair of Peripheral Ulcerative Keratitis With Corneal Perforation. Eslami M; Benito-Pascual B; Goolam S; Trinh T; Moloney G Front Med (Lausanne); 2022; 9():836873. PubMed ID: 35572993 [TBL] [Abstract][Full Text] [Related]
12. Superimposed fungal ulcer after fibrin glue sealant in infectious corneal ulcer. Byun YS; Kim MS Korean J Ophthalmol; 2011 Dec; 25(6):447-50. PubMed ID: 22131784 [TBL] [Abstract][Full Text] [Related]
13. Corneal Perforation Repair Using a Novel Lyophilized Amniotic Membrane Graft Technique: Plug and Patch. Hayek G; Francois J; Perone JM Am J Case Rep; 2023 Jun; 24():e939626. PubMed ID: 37339105 [TBL] [Abstract][Full Text] [Related]
15. Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation. Bessant DA; Dart JK Eye (Lond); 1994; 8 ( Pt 1)():22-8. PubMed ID: 8013714 [TBL] [Abstract][Full Text] [Related]
16. Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related? Mastorino L; Ortoncelli M; Avallone G; Quaglino P; Ribero S Int J Dermatol; 2022 Oct; 61(10):e370-e372. PubMed ID: 34865213 [No Abstract] [Full Text] [Related]
17. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study. Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676 [TBL] [Abstract][Full Text] [Related]
18. Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient. Zhang S; Lu L; Feng J; Hu Z; Song H; Yang L; Liu Y; Chen D; Wang T J Dermatolog Treat; 2023 Dec; 34(1):2229466. PubMed ID: 37369546 [TBL] [Abstract][Full Text] [Related]
19. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis. Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163 [TBL] [Abstract][Full Text] [Related]
20. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis. Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]